methylcobalamin (Universal Pharmaceutical Group )

甲钴胺 (万邦德制药集团)

Report date: 2025/03/06 14:53:10

Base Information

Drug Namemethylcobalamin (Universal Pharmaceutical Group )
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 stimulants
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversal Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversal Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A